Form C - Offering Statement:
SEC Accession No. 0001670254-22-000383
Filing Date
2022-04-22
Accepted
2022-04-21 21:18:47
Documents
12

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 11224
2 document_1.pdf EX-99 10360249
3 document_2.pdf EX-99 4422280
4 document_3.pdf EX-99 19849833
5 document_4.pdf EX-99 10956812
6 document_5.pdf EX-99 19849821
7 document_6.pdf EX-99 10956812
8 document_7.pdf EX-99 7655337
9 document_8.pdf EX-99 4625216
10 document_9.pdf EX-99 3856305
11 document_10.pdf EX-99 2811276
12 documents_list.htm EX-99 123
  Complete submission text file 0001670254-22-000383.txt   129061263
Mailing Address 1809 NEWTON ST UNIT 8A-2 AUSTIN TX 78704
Business Address 651 N. BROAD ST STE. 205 MIDDLETOWN DE 19709 (267) 634-9997
Vironix Health Inc. (Filer) CIK: 0001833036 (see all company filings)

EIN.: 850670188 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-30065 | Film No.: 22843111